These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 6684461

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Study of subacute toxicity of CDP-choline after 30 days of oral administration to rats.
    Romero A, Grau T, Sacristán A, Ortiz JA.
    Arzneimittelforschung; 1983; 33(7A):1035-8. PubMed ID: 6684460
    [Abstract] [Full Text] [Related]

  • 4. CDP-choline: acute toxicity study.
    Grau T, Romero A, Sacristán A, Ortiz JA.
    Arzneimittelforschung; 1983; 33(7A):1033-4. PubMed ID: 6684459
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effect of oral CDP-choline on experimental withdrawal syndrome.
    Tornos ME, Sacristán A, Ortiz JA.
    Arzneimittelforschung; 1983; 33(7A):1018-21. PubMed ID: 6684454
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effect of oral CDP-choline on acrylamide-induced lesion.
    Agut J, Font E, Sacristán A, Ortiz JA.
    Arzneimittelforschung; 1983; 33(7A):1029-33. PubMed ID: 6684458
    [Abstract] [Full Text] [Related]

  • 11. Pharmacological study of oral CDP-choline. Interaction with oxotremorine on the parasympathetic system.
    Tornos ME, Sacristán A, Ortiz JA.
    Arzneimittelforschung; 1983; 33(7A):1026-9. PubMed ID: 6684457
    [Abstract] [Full Text] [Related]

  • 12. Low-resolution autoradiography in rat brain after administering labelled CDP-choline.
    Romero A, Serratosa J, Sacristán A, Ortiz JA.
    Arzneimittelforschung; 1983; 33(7A):1054-6. PubMed ID: 6684465
    [Abstract] [Full Text] [Related]

  • 13. High-resolution autoradiography in mouse brain and cerebellum 10 days after radiolabelled CDP-choline administration.
    Romero A, Serratosa J, Sacristán A, Ortiz JA.
    Arzneimittelforschung; 1983; 33(7A):1058-60. PubMed ID: 6684467
    [Abstract] [Full Text] [Related]

  • 14. Treatment of chronic dyskinesia with CDP-choline.
    Arranz J, Ganoza C.
    Arzneimittelforschung; 1983; 33(7A):1071-3. PubMed ID: 6684469
    [Abstract] [Full Text] [Related]

  • 15. Bioavailability of methyl-14C CDP-choline by oral route.
    Agut J, Font E, Sacristán A, Ortiz JA.
    Arzneimittelforschung; 1983; 33(7A):1045-7. PubMed ID: 6684463
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. High-resolution autoradiography in mouse brain 24 h after radiolabelled CDP-choline administration.
    Romero A, Serratosa J, Sacristán A, Ortiz JA.
    Arzneimittelforschung; 1983; 33(7A):1056-8. PubMed ID: 6684466
    [Abstract] [Full Text] [Related]

  • 19. Subchronic intravenous toxicity studies with gamma-cyclodextrin in rats.
    Donaubauer HH, Fuchs H, Langer KH, Bär A.
    Regul Toxicol Pharmacol; 1998 Apr; 27(2):189-98. PubMed ID: 9671574
    [Abstract] [Full Text] [Related]

  • 20. Cerebral subcellular distribution of CDP-choline and/or its metabolites after oral administration of methyl-14C CDP-choline.
    Aguilar J, Giménez R, Bachs O, Enrich C, Agut J.
    Arzneimittelforschung; 1983 Apr; 33(7A):1051-3. PubMed ID: 6225438
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.